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The basic defect in cystic ﬁbrosis (CF) is well characterized, but the link between
defects in the CF transmembrane conductance regulator (CFTR), the causative gene
of CF disease, and the phenomenon of stagnant mucus is not well understood. It
has been shown that the ileal mucus in CF mice adheres to the epithelium, is
denser, and is less penetrable than that of wild-type mice and that apical addition
of 115mM NaHCO3 to mucus partially normalizes this mucus phenotype. Using
this knowledge of effects on ileal mucus, we develop an airway experimental set-
up. In the airway, CFTR is localized apically not to MUC5AC-expressing goblet
cells, but to the neighboring ciliated epithelial cells. This is similar to the small
intestine where the MUC2 secreting goblet cells are localized adjacent to the
CFTR expressing enterocytes. Using bead-tracking and mass spectrometry analysis,
we study the effects of therapies on the mucociliary transport rate, Muc5ac and
Muc5b secretion, and mucus clearance patterns in the bronchotracheal tree of both
wild-type and cystic ﬁbrosis porcine models as well as in rat airway explants.
Scanning electron microscopy is used to visualize the properties of the mucus layer,
and transmission electron microscopy is used to study mucin secretion in detail.
Preliminary results suggest the importance of bicarbonate in the proper unpacking
and secretion of mucins. We hypothesize that the restoration of bicarbonate to the
apical surface of the epithelium in combination with osmolytes may induce proper
mucin unpacking in CF epithelia, and therefore could relieve the mucus obstruction
that causes clinical problems for cystic ﬁbrosis patients.
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L. Eliasson1, A. Edlund1, J.L. Esguerra1, A. Wendt1, M. Flodstro¨m-Tullberg2.
1Lund University Diabetes Centre, Lund University, Dept Clinical Sciences Malmo¨,
Malmo¨, Sweden; 2Center for Infectious Medicine (CIM), Karolinska Institute,
Department of Medicine Huddinge, Stockholm, Sweden
Objectives: Patients with Cystic Fibrosis (CF) often have disturbances in glucose
metabolism including impaired insulin release. Here we aimed to test the hypothesis
that CFTR has a biological function in pancreatic beta-cells.
Methods: The whole-cell conﬁguration of the patch-clamp technique and a ramp
protocol was used to measure cAMP-activated currents in single mouse and human
beta-cells. Exocytosis was elicited by a train of ten depolarizations from −70 to 0
mV and was measured as an increase in membrane capacitance. Insulin release was
measured on mouse-and human islets.
Results: Forskolin evoked an increase in current that was inhibited by CFTR
antagonists (p< 0.001), CFTRinh-172 or GlyH-101. The cAMP-activated current
was also reduced by the Anoctamin1 (ANO1) chloride channel blocker AO1, where
the remaining part was inhibited by GlyH-101 (P< 0.01). The calculated CFTR
conductance was small and we propose that CFTR act as a regulator of ANO1. This
was further conﬁrmed by insulin secretion measurements. Glucose- and cAMP-
stimulated insulin secretion was reduced by 40% (p< 0.01) in the presence of
GlyH-101 in human and mouse islets, respectively. When AO1 was added, GlyH
had no further inhibitory effect, conﬁrming that CFTR controls ANO1. Moreover,
cAMP-ampliﬁed exocytosis was reduced by >40% after pre-incubation with CFTR
antagonists (P< 0.05).
Conclusion:We postulate that CFTR is an essential component in cAMP-dependent
insulin secretion and exocytosis in human and mouse beta-cells, and suggest that
impaired insulin secretion in patients with CF is caused by defect CFTR mediated
beta-cell exocytosis.
